Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

Soloff PH, George A, Nathan S, Schulz PM, Cornelius JR, Herring J, Perel JM.

J Clin Psychopharmacol. 1989 Aug;9(4):238-46.

PMID:
2768542
[PubMed - indexed for MEDLINE]
2.

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.

Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM.

Arch Gen Psychiatry. 1986 Jul;43(7):691-7.

PMID:
3521532
[PubMed - indexed for MEDLINE]
3.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
[PubMed - indexed for MEDLINE]
4.

Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.

Serban G, Siegel S.

Am J Psychiatry. 1984 Nov;141(11):1455-8.

PMID:
6388363
[PubMed - indexed for MEDLINE]
5.

Pharmacotherapy for patients with borderline personality disorder.

Gunderson JG.

Arch Gen Psychiatry. 1986 Jul;43(7):698-700. No abstract available.

PMID:
2872871
[PubMed - indexed for MEDLINE]
6.

Paradoxical effects of amitriptyline on borderline patients.

Soloff PH, George A, Nathan RS, Schulz PM, Perel JM.

Am J Psychiatry. 1986 Dec;143(12):1603-5.

PMID:
3538914
[PubMed - indexed for MEDLINE]
7.

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.

Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO.

Arch Gen Psychiatry. 1986 Jul;43(7):680-6.

PMID:
3521531
[PubMed - indexed for MEDLINE]
8.

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.

J Psychiatr Res. 2009 Apr;43(7):702-10. doi: 10.1016/j.jpsychires.2008.10.004. Epub 2008 Nov 26.

PMID:
19038406
[PubMed - indexed for MEDLINE]
9.

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

Am J Psychiatry. 1993 Dec;150(12):1843-8.

PMID:
8238640
[PubMed - indexed for MEDLINE]
10.

An open, noncomparative study of amoxapine in borderline disorders.

Jensen HV, Andersen J.

Acta Psychiatr Scand. 1989 Jan;79(1):89-93.

PMID:
2648768
[PubMed - indexed for MEDLINE]
11.

Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.

Soloff PH, George A, Nathan S, Schulz PM, Ulrich RF, Perel JM.

Psychopharmacol Bull. 1986;22(1):177-82. No abstract available.

PMID:
3523575
[PubMed - indexed for MEDLINE]
12.

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB.

Am J Psychiatry. 2005 Mar;162(3):621-4.

PMID:
15741486
[PubMed - indexed for MEDLINE]
13.

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

Frankenburg FR, Zanarini MC.

J Clin Psychiatry. 2002 May;63(5):442-6.

PMID:
12019669
[PubMed - indexed for MEDLINE]
14.

Effect of tranquilizers on borderline and schizotypal patients questioned.

Rockland LH.

Am J Psychiatry. 1985 May;142(5):665-6. No abstract available.

PMID:
3885764
[PubMed - indexed for MEDLINE]
15.

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

Müller-Siecheneder F, Müller MJ, Hillert A, Szegedi A, Wetzel H, Benkert O.

J Clin Psychopharmacol. 1998 Apr;18(2):111-20.

PMID:
9555596
[PubMed - indexed for MEDLINE]
16.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
[PubMed - indexed for MEDLINE]
17.

The significance of borderline and schizotypal overlap.

Plakun EM, Muller JP, Burkhardt PE.

Hillside J Clin Psychiatry. 1987;9(1):47-54.

PMID:
3653842
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
[PubMed - indexed for MEDLINE]
19.

Risperidone in the treatment of schizotypal personality disorder.

Koenigsberg HW, Reynolds D, Goodman M, New AS, Mitropoulou V, Trestman RL, Silverman J, Siever LJ.

J Clin Psychiatry. 2003 Jun;64(6):628-34.

PMID:
12823075
[PubMed - indexed for MEDLINE]
20.

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.

Zanarini MC, Frankenburg FR.

Am J Psychiatry. 2003 Jan;160(1):167-9.

PMID:
12505817
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk